Hi-Tech Pharmacal Management Discusses Q3 2013 Results – Earnings Call …

Hi-Tech Pharmacal Management Discusses Q3 2013 Results - Earnings Call ... Sale of our generic Flonase increased to $ 23 million from $ 21.8 mil...


Hi-Tech Pharmacal Management Discusses Q3 2013 Results – Earnings Call …
Sale of our generic Flonase increased to $ 23 million from $ 21.8 million last year. We sold more units at lower average prices, which led lower gross margin in the first quarter. As a Hi-Tech expanded our generic product line in the last 12 …
Read on
more

Leave a Reply